Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening (DECIDO)
Personalized Breast Cancer Screening: Assessment of Its Feasibility and Acceptability in the National Health System
Sponsor: Catalan Health Service
A NA clinical study on Breast Cancer, this trial is completed. The trial is conducted by Catalan Health Service and has accumulated 10 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2021 — Apr 2022 [monthly]
Active Not Recruiting NA
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Suspended → Recruiting
-
Jul 2020 — Dec 2020 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Mar 2019 — Jul 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Catalan Health Service
- Institut Català de la Salut
- Institut de Recerca Biomèdica de Lleida
For direct contact, visit the study record on ClinicalTrials.gov .